17 September 2015
Positive Impact (PI) has announced that it is now the exclusive UK distributor for InflammaDry, an in-practice test to aid the diagnosis of dry eye in just four easy steps.
InflammaDry is said by PI to be the first and only, rapid, in-practice test which detects MMP-9, a biomarker for inflammation that is consistently elevated in the tears of patients with dry eye disease.
Commenting on the announcement, joint managing director of PI, Nick Atkins, said: “We are delighted to be able to make this unique diagnostic tool available to UK dry eye practitioners in both optometry and ophthalmology.”
Mr Atkins added: “All other dry eye tests measure tear production and stability. InflammaDry recognises elevated levels of MMP-9 to identify patients that may otherwise be missed with other dry eye testing methods.”
He concluded: “This is a reliable and relatively low cost disposable test that is simple to use and gives a definitive result in just 10 minutes.”
For more information, visit the InflammaDry website or email its sales team.
Comments (0)
You must be logged in to join the discussion. Log in